Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Journal of Clinical Psychopharmacology|April 22, 2011
Association between citalopram serum levels and clinical improvement of patients with major depressionElnaz Ostad Haji, André Tadić, Stefanie Wagner, et al.Journal of Clinical Psychopharmacology|March 18, 2003
Clinical and neurobiological effects of tianeptine and paroxetine in major depressionThomas Nickel, Annette Sonntag, Julia Schill, et al.BMC Psychiatry|July 28, 2023
A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatientsFlorian Seemüller, Rebecca Schennach, Richard Musil, et al.Dialogues in Clinical Neuroscience|September 15, 2005
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressantsPierre Baumann, Sven Ulrich, Gabriel Eckermann, et al.Journal of Affective Disorders|November 20, 2021
Chronic vs non-chronic depression in psychiatric inpatient care - Data from a large naturalistic multicenter trialFlorian Seemüller, Miriam Kolter, Richard Musil, et al.Frontiers in Psychiatry|December 16, 2020
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic DisordersEwgeni Jakubovski, Anna Pisarenko, Carolin Fremer, et al.The Journal of Clinical Psychiatry|August 3, 2010
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm ProjectKatja Wiethoff, Michael Bauer, Thomas C Baghai, et al.Journal of Affective Disorders|May 11, 2011
Clinical predictors of response and remission in inpatients with depressive syndromesMichael Riedel, Hans-Jürgen Möller, Michael Obermeier, et al.Journal of Psychiatric Research|May 8, 2010
Response and remission criteria in major depression--a validation of current practiceMichael Riedel, Hans-Jürgen Möller, Michael Obermeier, et al.Journal of Affective Disorders|December 19, 2017
A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3)Roland Ricken, Katja Wiethoff, Thomas Reinhold, et al.Pageof 9